Karen Noblett, Chief Medical Officer at Axonics, Inc. (AXNX), sold 8,337 shares at $61.12 ($510K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Open-market sale of $510k AXNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.12 | 1,536 | $94K | 18.4% |
| 2 | $61.12 | 1,536 | $94K | 18.4% |
| 3 | $61.17 | 2,167 | $133K | 26.0% |
| 4 | $61.17 | 2,167 | $133K | 26.0% |
| 5 | $60.43 | 136 | $8K | 1.6% |
| 6 | $61.02 | 795 |
| $49K |
| 9.5% |
| Total | $61.13 avg | 8,337 | $510K | 100% |
| Filing → |
| AXNX | SELL | 2023-12-28 | $952K | — | Filing → |
| AXNX | SELL | 2022-09-20 | $5.1M | — | Filing → |
| AXNX | SELL | 2022-09-09 | $1.5M | — | Filing → |